Further, pathological studies have demonstrated that CBS patients have a significant loss of choline acetyltransferase (ChAT)-positive neurons within the nucleus basalis of Meynert compared to PSP (186). The gene discussed is CHAT; the disease is supranuclear palsy, progressive, 1.